- Home
- SOND vs DYAI Comparison
SOND vs DYAI Comparison
Compare SOND & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOND
- DYAI
- Stock Information
- Founded
- SOND 2014
- DYAI 1979
- Country
- SOND United States
- DYAI United States
- Employees
- SOND N/A
- DYAI N/A
- Industry
- SOND Hotels/Resorts
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SOND Consumer Discretionary
- DYAI Health Care
- Exchange
- SOND Nasdaq
- DYAI Nasdaq
- Market Cap
- SOND 27.0M
- DYAI 30.2M
- IPO Year
- SOND N/A
- DYAI 2004
- Fundamental
- Price
- SOND $1.69
- DYAI $0.99
- Analyst Decision
- SOND
- DYAI Strong Buy
- Analyst Count
- SOND 0
- DYAI 1
- Target Price
- SOND N/A
- DYAI $6.00
- AVG Volume (30 Days)
- SOND 19.7K
- DYAI 116.6K
- Earning Date
- SOND 11-03-2025
- DYAI 11-11-2025
- Dividend Yield
- SOND N/A
- DYAI N/A
- EPS Growth
- SOND N/A
- DYAI N/A
- EPS
- SOND N/A
- DYAI N/A
- Revenue
- SOND $606,649,000.00
- DYAI $4,135,078.00
- Revenue This Year
- SOND $46.47
- DYAI $34.23
- Revenue Next Year
- SOND N/A
- DYAI $19.57
- P/E Ratio
- SOND N/A
- DYAI N/A
- Revenue Growth
- SOND N/A
- DYAI 129.20
- 52 Week Low
- SOND $1.47
- DYAI $0.71
- 52 Week High
- SOND $5.76
- DYAI $2.20
- Technical
- Relative Strength Index (RSI)
- SOND 34.95
- DYAI 57.31
- Support Level
- SOND $1.81
- DYAI $0.94
- Resistance Level
- SOND $1.75
- DYAI $1.01
- Average True Range (ATR)
- SOND 0.10
- DYAI 0.05
- MACD
- SOND 0.01
- DYAI 0.01
- Stochastic Oscillator
- SOND 25.00
- DYAI 73.87
About SOND Sonder Holdings Inc.
Sonder Holdings Inc is engaged in providing short and long-term accommodations to travelers in various cities across North America, Europe, and the Middle East. The Sonder units in each apartment-style building and each hotel property are selected, designed, and managed directly by the Company. The Company generates revenues by providing short-term or month-to-month accommodations to its guests. The Company also provides accommodations to travelers through boutique hotels.
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.